SFA Therapeutics was honored to participate in the Fifteenth Annual BioNJ Meeting, where we had the opportunity to share our vision, science, and recent progress with a community of investors, industry leaders, and fellow innovators. 

We’re incredibly proud to share that our company presentation was awarded the Most Unique Innovation Award at this year’s event! While we couldn’t be there to accept the award, we’re grateful to Alexander Richter, Executive Director & Head of SciTech Scity, for accepting on our behalf. Pictured accepting the award on behalf of SFA Therapeutics is Alex Richter, joined by (from left) Alan Zaccone, Account Executive, Biotech & Pharma, CoreWeave, Kathleen Addison, Executive Director, Life Sciences, J.P. Morgan, Debbie Hart, President & CEO, BioNJ, and David Schwartz, Partner, Morgan Lewis.

Thank you, BioNJ, for this recognition. We look forward to continuing the conversations started at the meeting and to advancing our mission of delivering transformative treatments to patients in need.